Modulation of activation-induced cytidine deaminase by curcumin in helicobacter pylori-infected gastric epithelial cells

Helicobacter

Volumn 14, Issue 6, 2009, Pages 588-595

  Zaidi, Syed Faisal Haider ^a   Yamamoto, Takeshi ^a   Refaat, Alaa ^a   Ahmed, Kanwal ^a   Sakurai, Hiroaki ^a   Saiki, Ikuo ^a   Kondo, Takashi ^a   Usmanghani, Khan ^b   Kadowaki, Makoto ^a   Sugiyama, Toshiro ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

^b HAMDARD UNIVERSITY   (Pakistan)

Author keywords

Activation induced cytidine deaminase; Curcumin; H. pylori; NF B

Indexed keywords

ACTIVATION INDUCED CYTIDINE DEAMINASE; BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; CURCUMIN; DNA; I KAPPA B; I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; SN 50;

APOPTOSIS; ARTICLE; BACTERIAL STRAIN; BACTERIUM ADHERENCE; BACTERIUM ISOLATION; CANCER PATIENT; CHEMOPROPHYLAXIS; COCULTURE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DNA FRAGMENTATION; DOWN REGULATION; DRUG ACTIVITY; DRUG INHIBITION; ENZYME ACTIVATION; ENZYME DEGRADATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; HUMAN CELL; IMMUNOBLOTTING; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM; STOMACH CANCER; STOMACH CARCINOGENESIS; STOMACH EPITHELIUM;

CELL LINE, TUMOR; CURCUMIN; CYTIDINE DEAMINASE; DOWN-REGULATION; ENZYME ACTIVATION; EPITHELIAL CELLS; GASTRIC MUCOSA; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS;

HELICOBACTER PYLORI;

EID: 70449424143     PISSN: 10834389     EISSN: 15235378     Source Type: Journal    
DOI: 10.1111/j.1523-5378.2009.00724.x     Document Type: Article

References (39)

1. Goodwin CS, Armstrong JA. Microbiological aspects of Helicobacter pylori (Campylobacter pylori). Eur J Clin Microbiol Infect Dis 1990 9 : 1 13.
2. Covacci A, Telford JL, Giudice GD, Parsonnet J, Rappuoli R. Helicobacter pylori virulence and genetic geography. Science 1999 284 : 1328 1333.
3. Keates S, Hitti YS, Upton M, Kelly CP. Helicobacter pylori infection activates NF kappa B in gastric epithelial cells. Gastroenterology 1997 113 : 1099 1109.
4. Karin M. Nuclear factor-κB in cancer development and progression. Nature 2006 441 : 431 436.
5. Karin M, Neriah YB. Phosphorylation meets ubiquitination: the control of NF-κB activity. Annu Rev Immunol 2000 18 : 621 663.
6. Matsumoto Y, Marusawa H, Kinoshita K, Endo Y, Kou T, Morisawa T, Azuma T, Okazaki IM, Honjo T, Chiba T. Helicobacter pylori infection triggers aberrant expression of activation-induced cytidine deaminase in gastric epithelium. Nat Med 2007 13 : 470 476.
7. Marusawa H. Aberrant AID expression and human cancer development. Int J Biochem Cell Biol 2008 40 : 1399 1402.
8. Ralhan R, Pandey MK, Aggarwal BB. Nuclear factor-kappa B links carcinogenic and chemopreventive agents. Front Biosci 2009 1 : 45 60.
9. Malfertheiner P, Sipponen P, Naumann M, Moayyedi P, Megraud F, Xiao SD, Sugano K, Nyren O. Helicobacter pylori eradication has the potential to prevent gastric cancer: a state-of-the-art critique. Am J Gastroenterol 2005 100 : 2100 2115.
10. Han SU, Kim YB, Joo HT, Hahm KB, Lee WH, Cho YK, Kim DY, Kim MW. Helicobacter pylori infection promotes gastric carcinogenesis in a mice model. J Gastroenterol Hepatol 2002 17 : 253 261.
11. Mario FD, Cavallaro LG, Nouvenne A, et al. A curcumin-based 1-week triple therapy for eradication of Helicobacter pylori infection: something to learn from failure?. Helicobacter 2007 12 : 238 243.
12. Lee SY, Shin YW, Hahm KB. Phytoceuticals: mighty but ignored weapons against Helicobacter pylori infection. J Dig Dis 2008 9 : 129 139.
13. Zaidi SFH, Yamada K, Kadowaki M, Usmanghani K, Sugiyama T. Bactericidal activity of medicinal plants, employed for the treatment of gastrointestinal ailments, against Helicobacter pylori. J Ethnopharm 2009 121 : 286 291.
14. Wang YC, Huang TL. Screening of anti-Helicobacter pylori herbs deriving from Taiwanese folk medicinal plants. FEMS Immunol Med Microbiol 2005 43 : 295 300.
15. Zaidi SFH, Yoshida I, Butt F, Yusuf MA, Usmanghani K, Kadowaki M, Sugiyama T. Potent bactericidal constituents from Mallotus philippinensis against clarithromycin and metronidazole resistant strains of Japanese and Pakistani Helicobacter pylori. Biol Pharm Bull 2009 32 : 631 636.
16. Aggarwal BB, Harikumar KB. Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases. Int J Biochem Cell Biol 2009 41 : 40 59.
17. Mahady GB, Pendland SL, Yun G, Lu ZZ. Turmeric (Curcuma longa) and curcumin inhibit the growth of Helicobacter pylori, a group 1 carcinogen. Anticancer Res 2002 22 : 4179 4181.
18. Thayyullathil F, Chathoth S, Hago A, Patel M, Galadari S. Rapid reactive oxygen species (ROS) generation induced by curcumin leads to caspase-dependent and -independent apoptosis in L929 cells. Free Radic Biol Med 1999 27 : 945 950.
19. Foryst-Ludwig A, Neumann M, Schneider-Brachert W, Naumann M. Curcumin blocks NF-κB and the motogenic response in Helicobacter pylori-infected epithelial cells. Biochem Biophys Res Commun 2004 316 : 1065 1072.
20. Marchildon PA, Sugiyama T, Fukuda Y, Peacock JS, Asaka M, Shimoyama T, Graham DY. Evaluation of the effects of strain-specific antigen variation on the accuracy of serological diagnosis of Helicobacter pylori infection. J Clin Microbiol 2003 41 : 1480 1485.
21. Meyer F, Wilson KT, James SP. Modulation of innate cytokine responses by products of Helicobacter pylori. Infect Immunol 2000 68 : 6265 6272.
22. Loh JT, Torres VJ, Cover TL. Regulation of Helicobacter pylori cagA expression in response to salt. Cancer Res 2007 67 : 4709 4715.
23. Sellins KS, Cohen JJ. Gene induction by gamma-irradiation leads to DNA fragmentation in lymphocytes. J Immunol 1987 139 : 3199 3206.
24. Hayashi S, Sugiyama T, Yachi A, Yokota K, Hirai Y, Oguma K, Fuji N. A rapid and simple method to quantify Helicobacter pylori adhesion to human gastric MKN-28 cells. J Gastroenterol Hepatol 1997 12 : 373 375.
25. Hayashi S, Sugiyama T, Amano K, et al. Effect of Rebamipide, a novel antiulcer agent, on Helicobacter pylori adhesion to gastric epithelial cells. Antimicrob Agents Chemother 1998 42 : 1895 1899. (Pubitemid 28363066)
26. Backert S, Ziska E, Brinkmann V, Zimny-Arndt U, Fauconnier A, Jungblut PR, Naumann M, Meyer TF. Translocation of the Helicobacter pylori CagA protein in gastric epithelial cells by a type IV secretion apparatus. Cell Microbiol 2000 2 : 155 164.
27. Parkin DM, Bray FI, Devesa SS. Cancer burden in the year 2000. The global picture. Eur J Cancer 2001 37 : S4 S66.
28. Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 1997 349 : 1498 1504.
29. Marusawa H. Aberrant AID expression and human cancer development. Int J Biochem Cell Biol 2008 40 : 1399 1402.
30. Aggarwal BB, Kumar A, Bharti AC. Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res 2003 23 : 363 398.
31. Cheng AL, Hsu CH, Lin JK, et al. Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res 2001 21 : 2895 2900.
32. Dhillon N, Aggarwal BB, Li L, Chiao P, Sarkar F, Wolf RA, Kurzrock R. Phase II trial of curcumin, an NF-κB inhibitor, in patients with advanced pancreatic cancer. J Clin Oncol 2006 24 : 14151.
33. Sharma RA, McLelland HR, Hill KA, Ireson CR, Euden SA, Manson MM, Pirmohamed M, Marnett LJ, Gescher AJ, Steward WP. Pharmacodynamic and pharmacokinetic study of oral curcuma extract in patients with colorectal cancer. Clin Cancer Res 2001 7 : 1894 1900.
34. Cruz-Correa M, Shoskes DA, Sanchez P, Zhao R, Hylind LM, Wexner SD, Giardiello FM. Combination treatment with curcumin and quercetin of adenomas in familial adenomatous polyposis. Clin Gastroenterol Hepatol 2006 4 : 1035 1038.
35. Holt PR, Katz S, Kirshoff R. Curcumin therapy in inflammatory bowel disease: a pilot study. Dig Dis Sci 2005 50 : 2191 2193.
36. Lopez-Lazaro M. Anticancer and carcinogenic properties of curcumin: considerations for its clinical development as a cancer chemopreventive and chemotherapeutic agent. Mol Nutr Food Res 2008 52 : S103 27.
37. Aggarwal BB, Sung B. Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets. Cell 2008 30 : 85 94.
38. Sakurai H, Chiba H, Miyoshi H, Sugita T, Toriumi W. IκB kinases phosphorylates NF-κB p65 subunit on serine 536 in the transactivation domain. J Biol Chem 1997 274 : 30353 30356.
39. Suzuki S, Singhirunnusorn P, Mori A, Yamaoka S, Kitajima I, Saiki I, Sakurai H. Constitutive activation of TAK1 by HTLV-1 tax-dependent overexpression of TAB2 induces activation of JNK-ATF2 but not IKK-NF-κB. J Biol Chem 2007 282 : 25177 25181.